Special Advertising

Lpath Inc. (LPTN) Stock Quote

Detailed Quote for Lpath Inc. (LPTN)
$ 4.60   0.35 (+8.24%) Volume: 189.73k 2:56 PM EDT Apr 16, 2014
Today 5d 1m 3m 1y more
Last Price
4.60
Change $
0.35
Change %
8.24%
Tick
  
Bid
4.56
Bid Size
100
Ask
4.60
Ask Size
5,400
Open
4.44
High
4.79
Low
4.31
Prev Close
4.25
Last Trade
2:56
Volume
189.73k
52 Wk Hi
6.70
52 Wk Low
3.87
Market Cap
69.83m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
15,180,619
EPS (TTM)
-0.48
PE Ratio
N/A
Exchange
NSC
News and Media for Lpath Inc. (LPTN)
Sector News | Topic News
News for Lpath Inc. (LPTN)
Wed, Mar 05, 2014
7:30 AM New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab, in Traumatic Brain Injury Models - PR Newswire
Tue, Mar 04, 2014
8:00 AM Lpath to Present at Upcoming Roth Investor Conference - PR Newswire
Wed, Jan 22, 2014
7:30 AM Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP - PR Newswire
Thu, Dec 12, 2013
7:00 AM Lpath Withdraws From Pfizer's Process to Assign iSONEP Rights - PR Newswire
Thu, Nov 21, 2013
7:00 AM Lpath Announces New Antibody Program, Altepan(TM), Targeting Respiratory Disease - PR Newswire
Thu, Oct 17, 2013
8:52 AM Five Star Equities Issues New Research Reports on ARIA, CGIX, CYTR and LPTN - Accesswire
Wed, Jul 03, 2013
8:00 AM Lpath to Present at the 2013 JMP Healthcare Conference on July 9 - Marketwired
Thu, May 30, 2013
9:01 AM Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP - GlobeNewswire
Thu, May 23, 2013
9:00 AM Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP - GlobeNewswire
Thu, Mar 01, 2012
7:19 AM Keeping an eye on Lpath as shares look to build momentum - Accesswire
Tue, Dec 06, 2011
11:13 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
11:06 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
Thu, Dec 01, 2011
2:11 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
2:10 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
More News for LPTN >>

Tags for Lpath Inc.

Research stocks or mutual funds related to Lpath Inc. by keywords or tags. Find companies that have a similar focus to LPTN. The keywords below have been associated to LPTN by either user submission or electronic means.

microcurrent macular degeneration clinical trials database human monoclonal antibody clinical research trial clinical development clinical cost antibody protein clinical pharmacology cv therapeutics stock clinical research consulting outsourcing clinical trials angiogenesis inhibitors Biological Products corporate governance clinical investigators cra clinical research cv therapeutics clinical research clinical research investigators board of directors role clinical trials manager board of directors governance board compensation antibodies directors duties board governance human antibodies Drugs monospecific antibodies pain therapeutics cardiology clinical trials clinical trials conference board of directors info medical device clinical trial cedra clinical research board of directors compensation board of directors responsibility cellegy pharmaceuticals international clinical trials board responsibilities clinical data medical trials monoclonal antibody Healthcare corporate governance board of directors monitoring clinical research clinical research guidelines clinical outsourcing clinical research investigator monospecific antibody